EGFR and non-small cell lung carcinoma: Overexpression of EGFR has been found to be correlated with smoking and poorer overall survival in oropharyngeal SCC [56], and in NSCLC, EGFR mutations are more common in non-smokers than smokers and is clinically helpful in guiding the use of targeted therapy [57].